Endometriosis Trial, Recruiting NCT06331676 Sponsor: Hospices Civils de Lyon Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06331676
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are female
  • You are between 18 and 50 years old
  • You are currently using or have previously used hormonal contraception (such as the pill, patch, or hormonal coil)
  • You are willing and able to give written consent to participate
  • You have been diagnosed with a non-cancerous gynaecological condition (not affecting the womb lining) that requires a hysterectomy, hysteroscopy, or laparoscopy, OR you have been diagnosed with endometriosis requiring laparoscopy or hysterectomy
  • You are registered with the French social security system

Who may not be able to join:

  • You are currently pregnant or have been pregnant in the 3 months before the sample is taken
  • You are currently breastfeeding
  • You are going through natural menopause
  • You have received any hormonal treatment involving non-steroid hormones in the 3 months before the sample is taken (confirm with trial site)
  • You have a non-hormonal copper coil (IUD) fitted
  • You have a personal history of cancer of the breast, ovary, womb lining, or cervix
  • You have a condition called Lynch syndrome (an inherited condition that increases cancer risk)
  • You are under any form of legal protection such as guardianship or curatorship
  • You are currently detained or imprisoned by a legal or administrative decision
  • Your body mass index (BMI) is below 18.5 or above 30 (a measure of whether your weight is in a certain range for your height)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 27 85 51 70

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 June 2024
Est. completion
21 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Viability of all the cells forming the complex endometrial tissue generated ex vivo by tissue bioengineering.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov